vi

[ASAP] Synthesis and Antiviral/Fungicidal/Insecticidal Activities Study of Novel Chiral Indole Diketopiperazine Derivatives Containing Acylhydrazone Moiety

Journal of Agricultural and Food Chemistry
DOI: 10.1021/acs.jafc.0c00875




vi

[ASAP] Gel Properties of Soy Protein Isolate Modified by Lipoxygenase-Catalyzed Linoleic Acid Oxidation and Their Influence on Pepsin Diffusion and In Vitro Gastric Digestion

Journal of Agricultural and Food Chemistry
DOI: 10.1021/acs.jafc.0c00808




vi

[ASAP] Abietane Diterpenoids with Antioxidative Damage Activity from <italic toggle="yes">Rosmarinus officinalis</italic>

Journal of Agricultural and Food Chemistry
DOI: 10.1021/acs.jafc.0c01347




vi

[ASAP] Developing a Novel Nanoscale Porphyrinic Metal–Organic Framework: A Bifunctional Platform with Sensitive Fluorescent Detection and Elimination of Nitenpyram in Agricultural Environment

Journal of Agricultural and Food Chemistry
DOI: 10.1021/acs.jafc.0c01313




vi

[ASAP] Design, Synthesis, and Anti-ToCV Activity of Novel 4(3<italic toggle="yes">H</italic>)-Quinazolinone Derivatives Bearing Dithioacetal Moiety

Journal of Agricultural and Food Chemistry
DOI: 10.1021/acs.jafc.0c00086




vi

Clinical Dilemmas in Viral Liver Disease, 2nd Edition


 

The only evidence-based book to approach viral liver disease by focusing exclusively on the clinical dilemmas encountered by hepatologists and their medical teams

Although viral hepatitis is a growing public health risk around the world, the World Health Organization (WHO) views the elimination of hepatitis infection over the next several as an achievable goal. Effective pharmaceutical therapies are now available, yet medical teams caring for patients



Read More...




vi

The New Rules of Marketing and PR: How to Use Content Marketing, Podcasting, Social Media, AI, Live Video, and Newsjacking to Reach Buyers Directly, 7th Edition


 

The seventh edition of the pioneering guide to generating attention for your idea or business, packed with new and updated information

In the Digital Age, marketing tactics seem to change on a day-to-day basis. As the ways we communicate continue to evolve, keeping pace with the latest trends in social media, the newest online videos, the latest mobile apps, and all the other high-tech influences can seem an almost impossible task. How can you keep



Read More...




vi

United Arab Emirates woos scientists with new visa

Already awarded to more than 2,000 people, the visas last for 10 years




vi

Chemistry in Pictures: Violets are blue, and roses are black




vi

Video: Why the glowing rocks under New Jersey fascinate geochemists

The complex mineral collection beneath northern New Jersey may offer clues to how Earth formed and how soil affects water purity and plant growth




vi

Biotech firms consider contingency plans as the coronavirus outbreak hits CROs

The industry's reliance on China-based firms for chemistry services is in the spotlight




vi

United Arab Emirates woos scientists with new visa




vi

Bayer outsources chemistry R&amp;D to Nuvisan




vi

Structure of novel coronavirus spike protein solved in just weeks

Cryo-EM structure of key coronavirus protein could help develop vaccines against the virus




vi

Diagnosing the novel coronavirus leads to trade offs

Medical workers in China weigh the advantages and disadvantages of nucleic acid lab tests and CT lung scans




vi

Sanofi, BARDA team for coronavirus vaccine




vi

N&lt;sub&gt;2&lt;/sub&gt;O no laughing matter for Lonza in Visp




vi

Chemical firms see light at end of coronavirus tunnel

Facilities are reopening in China but spread of virus outside China is raising concerns




vi

Molded microfluidic device makes gel &#8220;apartments&#8221; for single cells

Hydrogel device allows localized treatment and analysis of 10,000 individual cells at a time




vi

Gilead and Moderna lead on coronavirus treatments

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine




vi

China's new place on the front lines of diagnosing and treating coronavirus disease

Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak




vi

Faulty probes are to blame for CDC coronavirus testing woes

The tests can still be used, CDC says, as urgency over possible outbreak grows




vi

Coronavirus cancels chemical events

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on




vi

Video: Designer surface captures pesky bubbles

Textured metal surface could help control foams in industrial processes, like in bioreactors




vi

Pittcon goes ahead despite coronavirus concerns

Product launches and champagne toasts at instrumentation conference bely worries about infection




vi

Faulty probes are to blame for CDC coronavirus testing woes

Early batches of the test can still be used, CDC says, while affirming it will deploy new kits




vi

$8.3 billion allocated for US coronavirus response

Congress opts for open-ended support for federal and local agencies




vi

Researchers in China report structure of the novel coronavirus bound to its human target

The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery




vi

Julie Zimmerman named editor in chief of &lt;i&gt;Environmental Science and Technology&lt;/i&gt;




vi

Coronavirus cancels chemical events

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on




vi

Gilead and Moderna lead on coronavirus treatments

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine




vi

Pittcon goes ahead despite coronavirus

Product launches and champagne toasts belied worries about infection




vi

First in vivo CRISPR gene editing in humans




vi

Ingevity CEO Wilson resigns unexpectedly




vi

How to answer difficult interview questions




vi

A full simulation of H1N1 flu virus

160-million-atom simulation reveals potential drug targets




vi

Gilead y Moderna lideran los tratamientos contra el coronavirus

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.




vi

Chemists work around coronavirus restrictions

C&EN looks at how scientists are adapting to travel restrictions and working from home




vi

Coronavirus forces cancellations of scientific meetings

Spring lineup of conferences and events frequented by chemists is slashed




vi

Podcast: How the coronavirus could disrupt the drug supply

Hear what C&EN's pharmaceutical editors have learned about how the coronavirus is affecting drug production in China and across the globe




vi

Merck and Princeton scientists create method to map cell-surface microenvironments

The technique, called MicroMapping, identifies potential protein interactions on and between cells




vi

Coronavirus hits Europe

Chemical makers brace for a slowdown on the continent




vi

Can old drugs take down a new coronavirus?

Several approved and well-studied small molecules could be repurposed as treatments for COVID-19




vi

How COVID-19 is changing my graduate school experience




vi

How we know disinfectants should kill the COVID-19 coronavirus

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking




vi

Bryan Brooks named editor in chief of &lt;i&gt;Environmental Science and Technology Letters&lt;/i&gt;




vi

Genentech Foundation provides $3 million grant to ACS Bridge Project




vi

Culture Biosciences raises $15 million for bioreactor service




vi

Gates, Wellcome, and Mastercard give $125 million for coronavirus treatments




vi

$8.3 billion allocated for US coronavirus response

Congress opts for open-ended support for federal and local agencies